Pdt Partners, LLC Insmed Inc Transaction History

Pdt Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$16.44 - $21.1 $169,595 - $217,667	10,316 Added 48.65%	31,521 $665,000
Q1 2023 May 15, 2023	SELL	$16.26 - $21.73 $198,128 - $264,780	-12,185 Reduced 36.49%	21,205 $361,000
Q4 2022 Feb 14, 2023	SELL	$16.98 - $23.15 $939,112 - $1.28 Million	-55,307 Reduced 62.35%	33,390 $667,000
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $1.85 Million - $2.5 Million	88,697 New	88,697 $1.91 Million
Q2 2022 Aug 15, 2022	SELL	$17.07 - $25.71 $488,219 - $735,331	-28,601 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$20.42 - $28.13 $584,032 - $804,546	28,601 New	28,601 $672,000

467

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.